ES2099428T3 - Composiciones farmaceuticas para inhalacion. - Google Patents

Composiciones farmaceuticas para inhalacion.

Info

Publication number
ES2099428T3
ES2099428T3 ES93906668T ES93906668T ES2099428T3 ES 2099428 T3 ES2099428 T3 ES 2099428T3 ES 93906668 T ES93906668 T ES 93906668T ES 93906668 T ES93906668 T ES 93906668T ES 2099428 T3 ES2099428 T3 ES 2099428T3
Authority
ES
Spain
Prior art keywords
inhalation
pharmaceutical compositions
dysfunction
nasal
breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93906668T
Other languages
English (en)
Inventor
Lewis James Baskeyfield
Graham Frederick Jay
Paul Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929205183A external-priority patent/GB9205183D0/en
Priority claimed from GB929205738A external-priority patent/GB9205738D0/en
Priority claimed from GB929205739A external-priority patent/GB9205739D0/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Application granted granted Critical
Publication of ES2099428T3 publication Critical patent/ES2099428T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE PRESENTA UN METODO DE TRATAMIENTO PARA DISFUNCION NASAL Y DE SENO QUE TOPICAMENTE COMPRENDE DE LA APLICACION DE UNA PREPARACION DE RABANO PICANTE, SINIGRINA O DE ISOTIOCIANATO DE ALILO PARA MUCOSAS AFECTADAS. SE PRESENTAN TAMBIEN PREPARACIONES PARA EL TRATAMIENTO DE DISFUNCION NASAL O DE SENO, QUE INCLUYEN PREPARACIONES DE RABANO PICANTE, SINIGRINA E ISOTIOCIANATO DE ALILO.
ES93906668T 1992-03-10 1993-03-10 Composiciones farmaceuticas para inhalacion. Expired - Lifetime ES2099428T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929205183A GB9205183D0 (en) 1992-03-10 1992-03-10 Formulation
GB929205738A GB9205738D0 (en) 1992-03-17 1992-03-17 Formulations
GB929205739A GB9205739D0 (en) 1992-03-17 1992-03-17 Formulations

Publications (1)

Publication Number Publication Date
ES2099428T3 true ES2099428T3 (es) 1997-05-16

Family

ID=27266086

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93906668T Expired - Lifetime ES2099428T3 (es) 1992-03-10 1993-03-10 Composiciones farmaceuticas para inhalacion.

Country Status (12)

Country Link
US (1) US5607662A (es)
EP (1) EP0630230B1 (es)
JP (1) JP2736168B2 (es)
AT (1) ATE145819T1 (es)
CA (1) CA2131285C (es)
DE (1) DE69306379T2 (es)
DK (1) DK0630230T3 (es)
ES (1) ES2099428T3 (es)
FI (1) FI110162B (es)
GR (1) GR3022527T3 (es)
NO (1) NO307203B1 (es)
WO (1) WO1993017663A1 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE220327T1 (de) 1992-09-29 2002-07-15 Inhale Therapeutic Syst Pulmonale abgabe von aktiven fragmenten des parathormons
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
ES2218543T3 (es) 1994-03-07 2004-11-16 Nektar Therapeutics Procedimiento y preparacion para la administracion de insulina por via pulmonar.
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
US6413496B1 (en) 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
US6192882B1 (en) * 1997-02-24 2001-02-27 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US6349719B2 (en) 1997-02-24 2002-02-26 Aradigm Corporation Formulation and devices for monitoring the efficacy of the delivery of aerosols
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US6197280B1 (en) 1997-09-09 2001-03-06 Bioglan Laboratories Limited Pharmaceutical compositions and devices for their administration
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
KR20010032303A (ko) * 1997-12-03 2001-04-16 후지야마 아키라 연질 펠렛상 약제 및 그 제조방법
US6458338B1 (en) 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
EP1238661A1 (en) * 1999-10-12 2002-09-11 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7368102B2 (en) 2001-12-19 2008-05-06 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
JP2006087815A (ja) * 2004-09-27 2006-04-06 Canon Inc 噴霧方法および該方法に基づく噴霧装置
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
HUE038452T2 (hu) 2007-11-13 2018-10-29 Meritage Pharma Inc Gyomor és bélrendszeri gyulladások kezelésére szolgáló kompozíciók
US9050368B2 (en) * 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
WO2010144865A2 (en) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CA3048677A1 (en) * 2017-03-07 2018-09-13 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201685B (en) * 1987-04-23 1990-12-28 Chinoin Gyogyszer Es Vegyeszet For producing pharmaceutical compositions for inhalation and compositions for scenting air containing volatile active component in cyclodextrine inclusion, and air-scenting composition
GB8820398D0 (en) * 1988-08-27 1988-09-28 Fisons Plc Pharmaceutical formulation
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers

Also Published As

Publication number Publication date
JP2736168B2 (ja) 1998-04-02
FI110162B (fi) 2002-12-13
NO943241D0 (no) 1994-09-01
DK0630230T3 (da) 1997-06-02
FI944123A0 (fi) 1994-09-08
NO307203B1 (no) 2000-02-28
NO943241L (no) 1994-09-01
CA2131285A1 (en) 1993-09-16
FI944123L (fi) 1994-09-08
EP0630230A1 (en) 1994-12-28
EP0630230B1 (en) 1996-12-04
GR3022527T3 (en) 1997-05-31
WO1993017663A1 (en) 1993-09-16
JPH07504432A (ja) 1995-05-18
ATE145819T1 (de) 1996-12-15
CA2131285C (en) 2004-06-29
US5607662A (en) 1997-03-04
DE69306379T2 (de) 1997-06-12
DE69306379D1 (de) 1997-01-16

Similar Documents

Publication Publication Date Title
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
FI935464A0 (fi) Klorfluorkolfria aerosolformulationer
AR042262A2 (es) Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis
PT1035834E (pt) Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
CL2009001682A1 (es) Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00).
ES2180592T3 (es) Formulaciones en aerosol libres de clorofluorocarbonos.
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
CO5150202A1 (es) Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
MX9701385A (es) Preparacion de producto combinado para usarse en enfermedades inmunologicas.
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ATE114244T1 (de) Pharmazeutische zusammensetzungen enthaltend fluticasonpropionat und oxikonazol oder dessen salz zur lokalen anwendung.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
IS1771B (is) Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
ATE233745T1 (de) Arzneistoffe
ES2128353T3 (es) Composicion topica que contiene penciclovir.
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
SE8002244L (sv) Nytt 1alfa,25-dihydroxi-cholekalciferolderivat, sett for framstellning samt anvendning derav som lekemedel och farmaceutiska kompositioner inehallande denna forening
ES2032572T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica para aplicacion topica sobre la piel.
HUP9800623A2 (hu) (+)-O-demetil-tramadol felhasználása fájdalomcsillapító hatású orális gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 630230

Country of ref document: ES